Medicare locked into AI healthcare vendor pricing for 5 years
H.R. 6197 — Health Tech Investment Act · Filed by John Joyce (R-PA) · 7 cosponsors · Introduced Nov 20, 2025 · Referred to committee
Your members of Congress
Enter a ZIP to see where your representative and both senators stood on this bill.
Looked up on this device — your ZIP is never stored on our servers.
What it does
This bill creates a special Medicare payment category for AI-powered healthcare services (like diagnostic algorithms cleared by the FDA). It guarantees these services receive payment based on manufacturer-submitted costs for at least 5 years, prevents Medicare from reclassifying them to lower-paying categories during that period, and expands eligibility to include AI tools used alongside other procedures. The primary beneficiaries are healthcare technology companies selling AI diagnostic and treatment tools to hospitals and clinics.
Why we flagged it
The bill's functional purpose is to shield AI healthcare vendors from Medicare cost-containment mechanisms by guaranteeing 5-year payment floors based on vendor-submitted costs, effectively creating a regulatory carve-out that prevents competitive pricing pressure.
What the text implies
- The 5-year payment floor applies even if competing AI tools become available at lower cost, locking Medicare into above-market rates and preventing beneficiary access to cheaper alternatives.
- Manufacturer cost submission (invoice prices, subscription fees, overhead) becomes the payment baseline with no independent verification or benchmarking, creating incentive for inflated cost claims.
The full analysis lists 5 implications of this text.
Who stands to gain
AI healthcare software vendors; Medical device manufacturers with FDA-cleared AI algorithms; Healthcare IT companies (Humana, UnitedHealth, Anthem, Align Technology, Avanir)